Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

New Business Opportunities For DEHP-Free Products? B Braun Thinks So

This article was originally published in The Gray Sheet

Executive Summary

Intravenous delivery product manufacturer B Braun is looking to gain market advantage based on what it sees as mounting recognition of the potential dangers of DEHP - a material that has been used in the manufacture of hospital equipment for decades

You may also be interested in...



News In Brief

InSightec submits ExAblate PMA to treat pain caused by bone metastases. AngioDynamics initiates NanoKnife software recall. Sequenom raises $62 million in secondary stock offering. More news briefs.

European Parliament Approves Revisions To Medical Device Directives

After adding new language on reprocessed devices, toxic substances and software, the European Parliament overwhelmingly approved a revision of the European Union's Medical Device Directives on March 29

European Parliament Approves Revisions To Medical Device Directives

After adding new language on reprocessed devices, toxic substances and software, the European Parliament overwhelmingly approved a revision of the European Union's Medical Device Directives on March 29

Related Content

Latest Headlines
See All
UsernamePublicRestriction

Register

MT022646

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel